3D Systems Indicates Rapid Growth in Dental Sector with $1B Market Potential as It Pursues Cost Reductions and MedTech Expansion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 05 2025
0mins
Should l Buy DDD?
Source: SeekingAlpha
Management Overview: CEO Jeffrey Graves reported a 13.8% year-over-year revenue decline to $91.2 million, attributing it to a challenging macro environment and reduced customer CapEx spending due to tariff uncertainties. The company is implementing cost structure adjustments, including divesting Oqton and 3DXpert, expected to impact Q4 results.
Product Launches and Market Opportunities: The introduction of new printer platforms, particularly the MJP 300W Plus, aims to enhance productivity and reduce waste. The full commercial release of the NextDent Jetted Denture Solution targets a $1 billion market opportunity in the dental sector, with regulatory processes underway for broader market access.
Financial Performance and Cost Management: The company reported a GAAP net loss of $18 million and ongoing cost management efforts, achieving a 24% reduction in non-GAAP operating expenses year-over-year. They are on track to deliver over $50 million in annualized savings by year-end.
Outlook and Analyst Sentiment: Management remains cautious about the macro environment and customer spending, while analysts express neutral to slightly cautious sentiment regarding margins and growth initiatives. The focus is on tangible financial improvements and the stabilization of revenue streams, particularly in the dental market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DDD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DDD
Wall Street analysts forecast DDD stock price to rise
4 Analyst Rating
1 Buy
3 Hold
0 Sell
Hold
Current: 2.050
Low
5.00
Averages
5.00
High
5.00
Current: 2.050
Low
5.00
Averages
5.00
High
5.00
About DDD
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
3D Systems Shares Slide for Eighth Session
- Stock Price Decline: 3D Systems' shares fell 2.73% to $2.14 on Tuesday, marking the eighth consecutive session of decline, indicating market concerns about the company's future performance.
- Poor Profitability Ratings: According to Seeking Alpha's ratings, DDD received a D for profitability and momentum, while its valuation score was B+, reflecting ongoing challenges faced by the company despite some positive aspects.
- Cost-Saving Initiatives: Management indicated during the Q3 earnings call that DDD is on track to achieve its $50 million annualized savings target by 2026, which could potentially improve cash flow conditions in the future.
- Revenue Decline: The latest earnings report revealed a 19.2% year-over-year drop in revenue to $91.2 million, missing market expectations, which further exacerbates investor concerns regarding the company's financial health.
See More
Low-Cap Industrial Stocks Face Weak EPS Revisions
- EPS Revision Analysis: As the earnings season approaches, several mid to low-cap industrial stocks have received an 'F' grade for earnings momentum, indicating significant downward pressure on analyst expectations for future earnings.
- Affected Companies: Companies such as Alight (ALIT), Alaska Air Group (ALK), and Apogee Enterprises (APOG) have all received an 'F' grade, highlighting severe challenges to their earnings outlook.
- Market Reaction Expectations: These companies may face cautious investor sentiment due to factors like heavy debt and high customer churn rates, which could negatively impact their stock performance.
- Industry Outlook: Despite the current poor EPS revision grades, the market remains optimistic about the industrial sector's prospects for 2026, potentially providing support for future investment opportunities.
See More
3D Systems to Present at 28th Annual Needham Growth Conference on January 13, 2026
- Conference Schedule: 3D Systems will present at the 28th Annual Needham Growth Conference on January 13, 2026, from 12:45 p.m. to 1:25 p.m. Eastern Time, showcasing the latest advancements in the 3D printing sector.
- Executive Participation: The presentation will be co-hosted by President and CEO Jeff Graves and Interim CFO Phyllis Nordstrom, highlighting the company's commitment to investor communication from its leadership.
- Live Webcast: The presentation will be available via live webcast and replay on the investor relations section of the company’s website, ensuring that investors can access key information promptly, thereby enhancing transparency.
- Company Background: For nearly 40 years, 3D Systems has been transforming product design and manufacturing through 3D printing technologies, serving high-value markets such as medical, aerospace, and durable goods, demonstrating its leadership in the additive manufacturing industry.
See More
Velo3D Secures $32.6M Federal Contract to Alleviate Production Bottlenecks
- Contract Award: Velo3D secured a $32.6 million contract with the Department of War aimed at alleviating production bottlenecks in critical weapons systems through its Project FORGE initiative, thereby enhancing the stability of defense supply chains.
- Technology Integration: The project incorporates metal additive manufacturing into production processes, which not only accelerates delivery times but also reduces reliance on traditional machining methods, improving overall production efficiency.
- Partnerships: Velo3D will collaborate with the U.S. Navy and the Defense Innovation Unit to design and qualify 3D-printed parts that meet military standards, ensuring scalable production capabilities to meet defense requirements.
- Market Reaction: Following the contract announcement, Velo3D's stock surged 11.45% in premarket trading to $12.07 per share, reflecting positive market sentiment regarding the company's potential in the defense sector.
See More
3D Systems Receives FDA Clearance to Expand VSP Orthopedics for Adolescents
- Commercial Acceleration: The FDA's clearance for 3D Systems' VSP®Orthopedics platform to include skeletally mature adolescents eliminates the need for case-by-case approvals, streamlining hospital workflows and converting previously off-label procedures into standard reimbursable surgeries, significantly enhancing market access efficiency.
- Market Potential: With over 1,200 new annual U.S. cases of osteosarcoma and Ewing sarcoma in adolescents, along with an additional 2,600 cases in young adults, the expanded indications will address a high-demand segment, driving growth in the company's medical technology sector.
- Sustainable Financial Model: VSP Orthopedics cases generate revenue through virtual planning service fees and patient-specific 3D-printed models, supporting double-digit annual growth rates and high gross margins in 3D Systems' Med Tech business, ensuring ongoing financial health.
- Strengthened Competitive Moat: As the only provider with FDA-cleared VSP solutions across craniomaxillofacial and orthopedic applications, 3D Systems has delivered over 400,000 patient-matched cases, further solidifying its market position in personalized healthcare solutions.
See More
88th Emerging Growth Conference Scheduled for December 10-11, 2025
- Conference Schedule: The 88th Emerging Growth Conference is set for December 10-11, 2025, featuring a diverse range of growth companies showcasing their innovative products and services, aimed at attracting investor interest.
- Presenting Companies: Keynote speakers from firms such as OSR Holdings (NASDAQ: OSRH) and SBC Medical Group (NASDAQ: SBC) will present, likely increasing investor engagement and interest in these companies.
- Interactive Opportunities: Attendees can submit questions to presenting companies, fostering communication between investors and firms, which enhances the effectiveness of investment decisions.
- Media Impact: The conference serves as a platform for companies to showcase their offerings, effectively attracting potential investors and enhancing market visibility, which could lead to potential stock price increases.
See More
3D Systems Shares Slide for Eighth Session
- Stock Price Decline: 3D Systems' shares fell 2.73% to $2.14 on Tuesday, marking the eighth consecutive session of decline, indicating market concerns about the company's future performance.
- Poor Profitability Ratings: According to Seeking Alpha's ratings, DDD received a D for profitability and momentum, while its valuation score was B+, reflecting ongoing challenges faced by the company despite some positive aspects.
- Cost-Saving Initiatives: Management indicated during the Q3 earnings call that DDD is on track to achieve its $50 million annualized savings target by 2026, which could potentially improve cash flow conditions in the future.
- Revenue Decline: The latest earnings report revealed a 19.2% year-over-year drop in revenue to $91.2 million, missing market expectations, which further exacerbates investor concerns regarding the company's financial health.
See More
Low-Cap Industrial Stocks Face Weak EPS Revisions
- EPS Revision Analysis: As the earnings season approaches, several mid to low-cap industrial stocks have received an 'F' grade for earnings momentum, indicating significant downward pressure on analyst expectations for future earnings.
- Affected Companies: Companies such as Alight (ALIT), Alaska Air Group (ALK), and Apogee Enterprises (APOG) have all received an 'F' grade, highlighting severe challenges to their earnings outlook.
- Market Reaction Expectations: These companies may face cautious investor sentiment due to factors like heavy debt and high customer churn rates, which could negatively impact their stock performance.
- Industry Outlook: Despite the current poor EPS revision grades, the market remains optimistic about the industrial sector's prospects for 2026, potentially providing support for future investment opportunities.
See More
3D Systems to Present at 28th Annual Needham Growth Conference on January 13, 2026
- Conference Schedule: 3D Systems will present at the 28th Annual Needham Growth Conference on January 13, 2026, from 12:45 p.m. to 1:25 p.m. Eastern Time, showcasing the latest advancements in the 3D printing sector.
- Executive Participation: The presentation will be co-hosted by President and CEO Jeff Graves and Interim CFO Phyllis Nordstrom, highlighting the company's commitment to investor communication from its leadership.
- Live Webcast: The presentation will be available via live webcast and replay on the investor relations section of the company’s website, ensuring that investors can access key information promptly, thereby enhancing transparency.
- Company Background: For nearly 40 years, 3D Systems has been transforming product design and manufacturing through 3D printing technologies, serving high-value markets such as medical, aerospace, and durable goods, demonstrating its leadership in the additive manufacturing industry.
See More
Velo3D Secures $32.6M Federal Contract to Alleviate Production Bottlenecks
- Contract Award: Velo3D secured a $32.6 million contract with the Department of War aimed at alleviating production bottlenecks in critical weapons systems through its Project FORGE initiative, thereby enhancing the stability of defense supply chains.
- Technology Integration: The project incorporates metal additive manufacturing into production processes, which not only accelerates delivery times but also reduces reliance on traditional machining methods, improving overall production efficiency.
- Partnerships: Velo3D will collaborate with the U.S. Navy and the Defense Innovation Unit to design and qualify 3D-printed parts that meet military standards, ensuring scalable production capabilities to meet defense requirements.
- Market Reaction: Following the contract announcement, Velo3D's stock surged 11.45% in premarket trading to $12.07 per share, reflecting positive market sentiment regarding the company's potential in the defense sector.
See More
3D Systems Receives FDA Clearance to Expand VSP Orthopedics for Adolescents
- Commercial Acceleration: The FDA's clearance for 3D Systems' VSP®Orthopedics platform to include skeletally mature adolescents eliminates the need for case-by-case approvals, streamlining hospital workflows and converting previously off-label procedures into standard reimbursable surgeries, significantly enhancing market access efficiency.
- Market Potential: With over 1,200 new annual U.S. cases of osteosarcoma and Ewing sarcoma in adolescents, along with an additional 2,600 cases in young adults, the expanded indications will address a high-demand segment, driving growth in the company's medical technology sector.
- Sustainable Financial Model: VSP Orthopedics cases generate revenue through virtual planning service fees and patient-specific 3D-printed models, supporting double-digit annual growth rates and high gross margins in 3D Systems' Med Tech business, ensuring ongoing financial health.
- Strengthened Competitive Moat: As the only provider with FDA-cleared VSP solutions across craniomaxillofacial and orthopedic applications, 3D Systems has delivered over 400,000 patient-matched cases, further solidifying its market position in personalized healthcare solutions.
See More
88th Emerging Growth Conference Scheduled for December 10-11, 2025
- Conference Schedule: The 88th Emerging Growth Conference is set for December 10-11, 2025, featuring a diverse range of growth companies showcasing their innovative products and services, aimed at attracting investor interest.
- Presenting Companies: Keynote speakers from firms such as OSR Holdings (NASDAQ: OSRH) and SBC Medical Group (NASDAQ: SBC) will present, likely increasing investor engagement and interest in these companies.
- Interactive Opportunities: Attendees can submit questions to presenting companies, fostering communication between investors and firms, which enhances the effectiveness of investment decisions.
- Media Impact: The conference serves as a platform for companies to showcase their offerings, effectively attracting potential investors and enhancing market visibility, which could lead to potential stock price increases.
See More
